Palvella Therapeutics (PVLA) EBIT Margin (2014 - 2024)
Palvella Therapeutics' EBIT Margin was -3318.87% in Q1 2024, down 2547.18 percentage points from -771.69% a year earlier and down 4349.35 percentage points from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) EBIT Margin (2014 - 2024) Analysis & Trends
For FY2023, EBIT Margin at Palvella Therapeutics came in at -27.72%, up 140.12 percentage points from FY2022.
- EBIT Margin shows a five-year change of +78.22 percentage points (FY2018 to FY2023).
- In earlier years, EBIT Margin was -167.84% in FY2022 (-2.87 pp), -164.97% in FY2021 (-49.29 pp), -115.68% in FY2020 (-57.00 pp) and -58.68% in FY2019 (+47.26 pp).
- The Q1 2024 figure marks the lowest quarterly EBIT Margin in data going back to Q1 2015.
- Compared with a year earlier, EBIT Margin was higher in five of the last eight quarters, with an average year-over-year change of -145.35 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2023 (a gain of 1227.53 percentage points); the worst was Q1 2024 (a drop of 2547.18 percentage points).
- Per Business Quant data, PVLA's EBIT Margin in the three quarters before Q1 2024 was 1030.48% (Q4 2023), -60.49% (Q3 2023) and 10.27% (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -3,318.87% |
| Dec 31, 2023 | 1,030.48% |
| Sep 30, 2023 | -60.49% |
| Jun 30, 2023 | 10.27% |
| Mar 31, 2023 | -771.69% |
| Dec 31, 2022 | -197.04% |
| Sep 30, 2022 | -226.59% |
| Jun 30, 2022 | -333.42% |
| Mar 31, 2022 | -66.70% |
| Dec 31, 2021 | -130.27% |
| Sep 30, 2021 | -468.62% |
| Jun 30, 2021 | -510.23% |
| Dec 31, 2020 | -661.21% |
| Sep 30, 2020 | -442.29% |
| Jun 30, 2020 | -41.39% |
| Mar 31, 2020 | -29.08% |
| Dec 31, 2019 | -7.70% |
| Sep 30, 2019 | -19.26% |
| Jun 30, 2019 | -229.37% |
| Mar 31, 2019 | -125.02% |
API Access
Palvella Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();